Literature DB >> 19840556

Usefulness of age and gender in the early triage of patients with acute chest pain having cardiac computed tomographic angiography.

Fabian Bamberg1, Quynh A Truong, Ron Blankstein, Khurram Nasir, Hang Lee, Ian S Rogers, Stephan Achenbach, Thomas J Brady, John T Nagurney, Maximilian F Reiser, Udo Hoffmann.   

Abstract

To identify the age- and gender-specific subpopulations of patients with acute chest pain in whom coronary computed tomographic angiography (CTA) will yield the greatest diagnostic benefit. Subjects with acute chest pain and an inconclusive initial evaluation (nondiagnostic electrocardiograhic findings, negative cardiac biomarkers) underwent contrast-enhanced 64-slice coronary CTA as a part of an observational cohort study. Independent investigators determined the presence of significant coronary stenosis (>50% luminal narrowing) and the occurrence of acute coronary syndrome (ACS) during the index hospitalization. We determined the diagnostic accuracy and effect on pretest probability of ACS using Bayes' theorem by age and gender. Of 368 patients (age 52.7 +/- 12 years, 61% men), 8% had ACS. The presence of significant coronary stenosis on CTA and the occurrence of ACS increased with age for both men and women (p <0.001). Cardiac CTA was highly sensitive and specific in women <65 years of age (sensitivity 100% and specificity >87%) and men <55 years of age (sensitivity 100% for men <45 years and 80% for men 45 to 54 years old; specificity >88.2%). Moreover, in these patients, coronary CTA led to restratification from low to high risk (for positive findings on CTA) or from low to very low risk (for negative findings on CTA). In contrast, a negative result on CTA did not result in restratification to a low-risk category in women >65 years and men >55 years old. In conclusion, the present analysis provides initial evidence that men <55 years and women <65 years might benefit more from cardiac CTA than older patients. Thus, age and gender might serve as simple criteria to appropriately select patients who would derive the greatest diagnostic benefit from coronary CTA in the setting of acute chest pain.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19840556      PMCID: PMC2765413          DOI: 10.1016/j.amjcard.2009.06.029

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  27 in total

Review 1.  Evaluation of the patient with acute chest pain.

Authors:  T H Lee; L Goldman
Journal:  N Engl J Med       Date:  2000-04-20       Impact factor: 91.245

2.  Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III).

Authors: 
Journal:  JAMA       Date:  2001-05-16       Impact factor: 56.272

3.  Comparative effects of aging and coronary heart disease on submaximal and maximal exercise.

Authors:  I S Kasser; R A Bruce
Journal:  Circulation       Date:  1969-06       Impact factor: 29.690

4.  Development and validation of a clinical score to estimate the probability of coronary artery disease in men and women presenting with suspected coronary disease.

Authors:  A P Morise; W J Haddad; D Beckner
Journal:  Am J Med       Date:  1997-04       Impact factor: 4.965

5.  Carotid intimal-medial thickness is related to cardiovascular risk factors measured from childhood through middle age: The Muscatine Study.

Authors:  P H Davis; J D Dawson; W A Riley; R M Lauer
Journal:  Circulation       Date:  2001-12-04       Impact factor: 29.690

6.  Coronary computed tomography angiography for early triage of patients with acute chest pain: the ROMICAT (Rule Out Myocardial Infarction using Computer Assisted Tomography) trial.

Authors:  Udo Hoffmann; Fabian Bamberg; Claudia U Chae; John H Nichols; Ian S Rogers; Sujith K Seneviratne; Quynh A Truong; Ricardo C Cury; Suhny Abbara; Michael D Shapiro; Jamaluddin Moloo; Javed Butler; Maros Ferencik; Hang Lee; Ik-Kyung Jang; Blair A Parry; David F Brown; James E Udelson; Stephan Achenbach; Thomas J Brady; John T Nagurney
Journal:  J Am Coll Cardiol       Date:  2009-05-05       Impact factor: 24.094

7.  Estimating the likelihood of significant coronary artery disease.

Authors:  D B Pryor; F E Harrell; K L Lee; R M Califf; R A Rosati
Journal:  Am J Med       Date:  1983-11       Impact factor: 4.965

8.  Use of a simple clinical score to predict prognosis of patients with normal or mildly abnormal resting electrocardiographic findings undergoing evaluation for coronary artery disease.

Authors:  Kheng-Thye Ho; Todd D Miller; David O Hodge; Kent R Bailey; Raymond J Gibbons
Journal:  Mayo Clin Proc       Date:  2002-06       Impact factor: 7.616

9.  ACC/AHA guideline update for the management of patients with unstable angina and non-ST-segment elevation myocardial infarction--2002: summary article: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee on the Management of Patients With Unstable Angina).

Authors:  Eugene Braunwald; Elliott M Antman; John W Beasley; Robert M Califf; Melvin D Cheitlin; Judith S Hochman; Robert H Jones; Dean Kereiakes; Joel Kupersmith; Thomas N Levin; Carl J Pepine; John W Schaeffer; Earl E Smith; David E Steward; Pierre Theroux; Raymond J Gibbons; Joseph S Alpert; David P Faxon; Valentin Fuster; Gabriel Gregoratos; Loren F Hiratzka; Alice K Jacobs; Sidney C Smith
Journal:  Circulation       Date:  2002-10-01       Impact factor: 29.690

10.  Prediction of the need for intensive care in patients who come to emergency departments with acute chest pain.

Authors:  L Goldman; E F Cook; P A Johnson; D A Brand; G W Rouan; T H Lee
Journal:  N Engl J Med       Date:  1996-06-06       Impact factor: 91.245

View more
  1 in total

1.  Sex differences in the effectiveness of early coronary computed tomographic angiography compared with standard emergency department evaluation for acute chest pain: the rule-out myocardial infarction with Computer-Assisted Tomography (ROMICAT)-II Trial.

Authors:  Quynh A Truong; Douglas Hayden; Pamela K Woodard; Ruth Kirby; Eric T Chou; John T Nagurney; Stephen D Wiviott; Jerome L Fleg; David A Schoenfeld; James E Udelson; Udo Hoffmann
Journal:  Circulation       Date:  2013-05-17       Impact factor: 29.690

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.